Trial NCT01876251

View at ClinicalTrials.gov 
Org. Study IDs: A8641016
Secondary IDs: 2013-000659-41

Last trial update was posted on 2019-03-15

MeSH Interventions

Docetaxel Nirogacestat

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer Metastatic

Stopping Reasons

The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014 development. There were no safety/efficacy concerns behind the decision.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID